BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2192002)

  • 1. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens.
    Robledo MA; Kim SC; Korman NJ; Stanley JR; Labib RS; Futamura S; Anhalt GJ
    J Invest Dermatol; 1990 Jun; 94(6):793-7. PubMed ID: 2192002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 230-kD basic protein is the major bullous pemphigoid antigen.
    Mueller S; Klaus-Kovtun V; Stanley JR
    J Invest Dermatol; 1989 Jan; 92(1):33-8. PubMed ID: 2462597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.
    Labib RS; Anhalt GJ; Patel HP; Mutasim DF; Diaz LA
    J Immunol; 1986 Feb; 136(4):1231-5. PubMed ID: 2418109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
    Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
    Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid antigen localization suggests an intracellular association with hemidesmosomes.
    Westgate GE; Weaver AC; Couchman JR
    J Invest Dermatol; 1985 Mar; 84(3):218-24. PubMed ID: 2579167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular heterogeneity of the bullous pemphigoid antigen as detected by immunoblotting].
    Izumi H; Hosokawa H
    Nihon Hifuka Gakkai Zasshi; 1989 Jul; 99(8):871-5. PubMed ID: 2685419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
    Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
    J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
    Allen J; Shears E; Powell J; Wojnarowska F
    Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen.
    Zhu XJ; Niimi Y; Bystryn JC
    J Invest Dermatol; 1990 Jun; 94(6):817-21. PubMed ID: 1693941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ-bound antibodies eluted from the skin of patients with bullous pemphigoid are preferentially directed against the 230-kD bullous pemphigoid antigen.
    Korman NJ
    J Invest Dermatol; 1995 Dec; 105(6):824-30. PubMed ID: 7490478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
    Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
    J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin.
    Onodera Y; Shimizu H; Hashimoto T; Ishiko A; Ebihara T; Tanaka M; Nishikawa T
    J Invest Dermatol; 1994 May; 102(5):686-90. PubMed ID: 8176249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel bullous pemphigoid antigen (BP125) located in the deeper layers of the basement membrane zone.
    Gao SQ; Bystryn JC
    Arch Dermatol; 1994 Jul; 130(7):873-8. PubMed ID: 8024275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA.
    Rico MJ; Korman NJ; Stanley JR; Tanaka T; Hall RP
    J Immunol; 1990 Dec; 145(11):3728-33. PubMed ID: 1700993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.
    Ghohestani RF; Nicolas JF; Kanitakis J; Claudy A
    J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins.
    Tanaka M; Hashimoto T; Amagai M; Shimizu N; Ikeguchi N; Tsubata T; Hasegawa A; Miki K; Nishikawa T
    J Invest Dermatol; 1991 Oct; 97(4):725-8. PubMed ID: 1940445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of bullous pemphigoid antibodies in dermal-epidermal separation.
    Haustein UF
    J Invest Dermatol; 1989 Jan; 92(1):133. PubMed ID: 2642509
    [No Abstract]   [Full Text] [Related]  

  • 18. Western blot analysis of the antigen in pemphigoid gestationis.
    Kelly SE; Bhogal BS; Wojnarowska F; Whitehead P; Leigh IM; Black MM
    Br J Dermatol; 1990 Apr; 122(4):445-9. PubMed ID: 2186774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two groups of bullous pemphigoid antigens are identified by affinity-purified antibodies.
    Meyer LJ; Taylor TB; Kadunce DP; Zone JJ
    J Invest Dermatol; 1990 May; 94(5):611-6. PubMed ID: 2182719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lichen planus pemphigoides: identification of 180 kd hemidesmosome antigen.
    Tamada Y; Yokochi K; Nitta Y; Ikeya T; Hara K; Owaribe K
    J Am Acad Dermatol; 1995 May; 32(5 Pt 2):883-7. PubMed ID: 7722050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.